• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定肾透明细胞癌中的 microRNA 编辑位点。

Identification of microRNA editing sites in clear cell renal cell carcinoma.

机构信息

State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.

College of Landscape and Horticulture, Yunnan Agricultural University, Kunming, 650201, Yunnan, China.

出版信息

Sci Rep. 2023 Sep 13;13(1):15117. doi: 10.1038/s41598-023-42302-y.

DOI:10.1038/s41598-023-42302-y
PMID:37704698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10499803/
Abstract

Clear cell renal cell carcinoma (ccRCC) is a malignant tumor originating from the renal tubular epithelium. Although the microRNAs (miRNAs) transcriptome of ccRCC has been extensively studied, the role of miRNAs editing in ccRCC is largely unknown. By analyzing small RNA sequencing profiles of renal tissues of 154 ccRCC patients and 22 normal controls, we identified 1025 miRNA editing sites from 246 pre-miRNAs. There were 122 editing events with significantly different editing levels in ccRCC compared to normal samples, which include two A-to-I editing events in the seed regions of hsa-mir-376a-3p and hsa-mir-376c-3p, respectively, and one C-to-U editing event in the seed region of hsa-mir-29c-3p. After comparing the targets of the original and edited miRNAs, we found that hsa-mir-376a-1_49g, hsa-mir-376c_48g and hsa-mir-29c_59u had many new targets, respectively. Many of these new targets were deregulated in ccRCC, which might be related to the different editing levels of hsa-mir-376a-3p, hsa-mir-376c-3p, hsa-mir-29c-3p in ccRCC compared to normal controls. Our study sheds new light on miRNA editing events and their potential biological functions in ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是一种起源于肾小管上皮的恶性肿瘤。虽然 ccRCC 的 microRNAs(miRNAs)转录组已经得到了广泛的研究,但 miRNA 编辑在 ccRCC 中的作用在很大程度上是未知的。通过分析 154 例 ccRCC 患者和 22 例正常对照的肾组织小 RNA 测序谱,我们从 246 个前体 miRNA 中鉴定出 1025 个 miRNA 编辑位点。与正常样本相比,ccRCC 中有 122 个编辑事件的编辑水平存在显著差异,其中包括 hsa-mir-376a-3p 和 hsa-mir-376c-3p 种子区的两个 A-to-I 编辑事件,以及 hsa-mir-29c-3p 种子区的一个 C-to-U 编辑事件。在比较原始和编辑 miRNA 的靶标后,我们发现 hsa-mir-376a-1_49g、hsa-mir-376c_48g 和 hsa-mir-29c_59u 分别具有许多新的靶标。这些新的靶标中的许多在 ccRCC 中被下调,这可能与 hsa-mir-376a-3p、hsa-mir-376c-3p、hsa-mir-29c-3p 在 ccRCC 中的编辑水平与正常对照相比存在差异有关。我们的研究为 miRNA 编辑事件及其在 ccRCC 中的潜在生物学功能提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/c02239c9fba8/41598_2023_42302_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/108de52c5790/41598_2023_42302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/e8259aab5dc0/41598_2023_42302_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/9786c0f23f74/41598_2023_42302_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/ed0e75bab36e/41598_2023_42302_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/c6e3a7c9208a/41598_2023_42302_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/c02239c9fba8/41598_2023_42302_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/108de52c5790/41598_2023_42302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/e8259aab5dc0/41598_2023_42302_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/9786c0f23f74/41598_2023_42302_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/ed0e75bab36e/41598_2023_42302_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/c6e3a7c9208a/41598_2023_42302_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/10499803/c02239c9fba8/41598_2023_42302_Fig6_HTML.jpg

相似文献

1
Identification of microRNA editing sites in clear cell renal cell carcinoma.鉴定肾透明细胞癌中的 microRNA 编辑位点。
Sci Rep. 2023 Sep 13;13(1):15117. doi: 10.1038/s41598-023-42302-y.
2
Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000- axis in malignant metastasis of clear cell renal cell carcinoma.综合分析揭示 hsa_circ_0037858/miR-5000- 轴在透明细胞肾细胞癌恶性转移中的作用。
Aging (Albany NY). 2023 Jun 27;15(12):5399-5411. doi: 10.18632/aging.204790.
3
MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.透明细胞肾细胞癌中的 microRNA 表达谱分析:关键 microRNA 的鉴定与功能验证
PLoS One. 2015 May 4;10(5):e0125672. doi: 10.1371/journal.pone.0125672. eCollection 2015.
4
Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.构建 circRNA/miRNA/mRNA 调控网络,探索透明细胞肾细胞癌的潜在发病机制和治疗选择。
Sci Rep. 2020 Aug 12;10(1):13659. doi: 10.1038/s41598-020-70484-2.
5
A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.一个 miRNA-临床预后模型,用于预测肾透明细胞癌的总生存期。
Cancer Med. 2021 Sep;10(17):6128-6139. doi: 10.1002/cam4.4148. Epub 2021 Jul 21.
6
miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.微小RNA-靶标网络揭示了miR-124通过靶向CAV1和FLOT1成为促进肾透明细胞癌侵袭行为的关键微小RNA。
Oncotarget. 2015 May 20;6(14):12543-57. doi: 10.18632/oncotarget.3815.
7
Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.miR-27a-3p的表达是透明细胞肾细胞癌复发的独立预测因素。
Oncotarget. 2015 Aug 28;6(25):21645-54. doi: 10.18632/oncotarget.4064.
8
Determination of the key ccRCC-related molecules from monolayer network to three-layer network.从单层网络到三层网络确定关键 ccRCC 相关分子。
Cancer Genet. 2021 Aug;256-257:40-47. doi: 10.1016/j.cancergen.2021.03.005. Epub 2021 Apr 20.
9
Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma.miR-27a-3p 与 CDH5 表达呈负相关,可作为透明细胞肾细胞癌增殖和转移的诊断生物标志物。
Pathol Res Pract. 2021 Apr;220:153393. doi: 10.1016/j.prp.2021.153393. Epub 2021 Mar 11.
10
circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.环状 RNA CHST15 是一种新型的预后生物标志物,通过 miR-125a-5p/EIF4EBP1 轴促进肾透明细胞癌细胞的增殖和转移。
Mol Cancer. 2021 Dec 18;20(1):169. doi: 10.1186/s12943-021-01449-w.

引用本文的文献

1
Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies.肾细胞癌中微小RNA的靶向治疗:新兴治疗策略
Int J Clin Oncol. 2025 Aug 21. doi: 10.1007/s10147-025-02856-5.
2
ncRNA Editing: Functional Characterization and Computational Resources.非编码RNA编辑:功能表征与计算资源
Methods Mol Biol. 2025;2883:455-495. doi: 10.1007/978-1-0716-4290-0_20.
3
Identification of prognostic RNA editing profiles for clear cell renal carcinoma.透明细胞肾细胞癌预后性RNA编辑图谱的鉴定

本文引用的文献

1
Characterizing microRNA editing and mutation sites in Autism Spectrum Disorder.表征自闭症谱系障碍中的微小RNA编辑和突变位点。
Front Mol Neurosci. 2023 Jan 20;15:1105278. doi: 10.3389/fnmol.2022.1105278. eCollection 2022.
2
Characterizing Relevant MicroRNA Editing Sites in Parkinson's Disease.鉴定帕金森病相关的 microRNA 编辑位点。
Cells. 2022 Dec 24;12(1):75. doi: 10.3390/cells12010075.
3
Identification of microRNA editing sites in three subtypes of leukemia.白血病三种亚型中微小RNA编辑位点的鉴定。
Front Med (Lausanne). 2024 Jul 18;11:1390803. doi: 10.3389/fmed.2024.1390803. eCollection 2024.
4
Improved lung cancer classification by employing diverse molecular features of microRNAs.通过利用微小RNA的多种分子特征改进肺癌分类
Heliyon. 2024 Feb 10;10(4):e26081. doi: 10.1016/j.heliyon.2024.e26081. eCollection 2024 Feb 29.
Front Mol Biosci. 2022 Nov 14;9:1014288. doi: 10.3389/fmolb.2022.1014288. eCollection 2022.
4
BCAT1, as a prognostic factor for HCC, can promote the development of liver cancer through activation of the AKT signaling pathway and EMT.BCAT1 作为 HCC 的预后因素,可以通过激活 AKT 信号通路和 EMT 促进肝癌的发展。
J Mol Histol. 2023 Feb;54(1):25-39. doi: 10.1007/s10735-022-10108-3. Epub 2022 Nov 7.
5
BCAT1 promotes lung adenocarcinoma progression through enhanced mitochondrial function and NF-κB pathway activation.BCAT1 通过增强线粒体功能和 NF-κB 通路激活促进肺腺癌进展。
J Zhejiang Univ Sci B. 2022;23(9):760-769. doi: 10.1631/jzus.B2100985.
6
Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma.叶酸酶 MTHFD2 将一碳代谢与神经胶质瘤中的未折叠蛋白反应联系起来。
Cancer Lett. 2022 Nov 28;549:215903. doi: 10.1016/j.canlet.2022.215903. Epub 2022 Sep 8.
7
ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis.转录激活因子 4/原癌基因 c-Myc 通过调节还原型叶酸载体蛋白 2 促进非小细胞肺癌的进展。
Dis Markers. 2022 Aug 22;2022:7527996. doi: 10.1155/2022/7527996. eCollection 2022.
8
RASSF8-AS1 displays low expression in colorectal cancer and up-regulates RASSF8 to suppress cell invasion and migration.RASSF8-AS1 在结直肠癌中表达水平较低,上调 RASSF8 可抑制细胞侵袭和迁移。
Pathol Res Pract. 2022 Sep;237:153996. doi: 10.1016/j.prp.2022.153996. Epub 2022 Jun 30.
9
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).ATF4 激活和整合应激反应(ISR)导致的透明细胞肾细胞癌中的转录和代谢重编程。
Mol Carcinog. 2022 Sep;61(9):851-864. doi: 10.1002/mc.23437. Epub 2022 Jun 21.
10
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.表观遗传调控的 miR-30a/c-5p 可直接靶向 TWIST1 并抑制 ccRCC 细胞的侵袭能力。
Transl Res. 2022 Nov;249:110-127. doi: 10.1016/j.trsl.2022.06.009. Epub 2022 Jun 11.